Advanced Filters
noise

neoplasms Clinical Trials

A listing of neoplasms medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Found 14,282 clinical trials
J Jianhong Peng, Doctor

Modified Sandwich Therapeutic Regimen for Locally Advanced Rectal Cancer

In the treatment of locally advanced rectal cancer, the short-term and long-term efficacy of the traditional sandwich regimen has not reached satisfactory efficacy. For this reason, the concept of reducing the dose of postoperative chemotherapy or directly moving forward the full amount of postoperative chemotherapy was proposed, which is called …

18 - 75 years of age All Phase 2
A Amy Lord, MD

EMVI as a Determinant of Metastasis in Colorectal Cancer

Bowel cancer is the fourth most commonly occurring cancer and the second highest cause of cancer deaths in the UK. Despite advances in treatment, over 40% of patients will die within 5 years. This is normally due to spread of the cancer to other organs (called metastases). Much of the …

16 - 100 years of age All Phase N/A
S Susan Sharry

XL092 in Patients With Metastatic Castration-Resistant Prostate Cancer

The purpose of this study is to determine how well the study drug XL092 is helping to treat a participant's cancer after 16 weeks of treatment. Researchers will also look at how safe the XL092 is and how well the XL092 is working. XL092 is an oral tablet that will …

18 years of age Male Phase 2
K Kato Rans, MD

Metastasis-directed Therapy in Oligoprogressive Castration-refractory Prostate Cancer

Evaluation of the impact of metastasis-directed therapy in patients with castration-refractory prostate cancer and a maximum of 5 progressive lesions.

18 years of age Male Phase 3
T Tianqiang Song, PH.D.

Stereotactic Radiosurgery Versus Radiofrequency Ablation for Primary Liver Cancer

A phase II clinical trial of stereotactic radiosurgery versus radiofrequency ablation in the treatment of inoperable primary liver cancer in specific sites

18 - 75 years of age All Phase 2
L Lisa C. Flowers

Screening Strategies Among High-risk Populations for Anal Cancer

The goal of the proposed research is to 1) examine the performance of emerging screening methods for anal high-grade squamous intraepithelial lesion (aHSIL), a precancerous condition of anal cancer, among populations at high risk for anal cancer and 2) characterize DNA methylation, immunologic response, and environmental factors associated with aHSIL.

30 - 80 years of age All Phase N/A

An Acupuncture Study for Cancer Survivors With Joint Pain

The purpose of this study is to see whether acupuncture is a practical (feasible) treatment for cancer survivors with joint pain.

18 years of age All Phase N/A
W Wei Peng Yong

Neoadjuvant ADG126 and Pembrolizumab in Locally Advanced Colorectal Cancer

This is a single site, open-label, single-arm phase II study to determine feasibility, tolerability, and preliminary efficacy of neoadjuvant ADG126 and pembrolizumab in stage II or III colorectal cancer.

21 years of age All Phase 2
H Huojun Zhang, M.D.

Hypofractionated Post-prostatectomy Radiotherapy (HYPORT)for Localized Prostate Cancer

The aim of this trial is to compare the safety outcomes of Hypofractionated postprostatectomy radiotherapy (HYPORT) and Conventionally fractionated postprostatectomy radiotherapy(COPORT) in treating patients with localized prostate cancer. Accumulating evidence has proven the safety and feasibility of HYPORT for localized prostate cancer.But for localized prostate cancer,the optimal dose per fraction …

years of age Male Phase N/A
E Emilia Viglasska, MSc

Dornase Alfa and Cisplatin in Refractory Germ Cell Cancer.

Germ cell tumors (GCTs) are highly curable malignancies; however, a subset of patients with relapsed or refractory disease after first- and second-line chemotherapy have a very poor prognosis, with long-term survival rates below 5%. New therapeutic strategies are needed in this setting. Emerging evidence indicates that extracellular DNA and markers …

18 years of age Male Phase 2

Simplify language using AI